Leon O. Moulder Jr

Chief Executive Officer at Zenas Biopharma · 7 reported transactions in 2 companies · latest trade May 18, 2026

Their record

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move −6.2%, S&P 500 −2.8% over the same days.

1 more is too recent to measure.

May 18, 2026 · ZBIO

$1.01M

S&P 500 +4.2%thru Oct 29

Feb 2, 2026 · ZBIO

$1.02M

S&P 500 +10.6%thru Oct 29

Jan 9, 2026 · ZBIO

$331K

S&P 500 +10.8%thru Oct 29

Jan 8, 2026 · ZBIO

$489K

S&P 500 +11.6%thru Oct 29

Jan 7, 2026 · ZBIO

$819K

S&P 500 +11.6%thru Oct 29

Oct 7, 2025 · ZBIO

$769.9K

S&P 500 +15.0%thru Oct 29

7 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Executive Officer at Zenas Biopharma · 7 reported transactions in 2 companies · latest trade May 18, 2026

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move −6.2%, S&P 500 −2.8% over the same days.

1 more is too recent to measure.